SLATE Therapeutics is dedicated to revolutionizing the treatment of chronic rhinosinusitis (CRS) with SilexGel, a novel sol-gel hydrogel technology. Its mission is to improve patients' quality of life through innovative and effective treatments. SilexGel is a cutting-edge platform technology designed for the systemic and localized delivery of therapeutics. Unlike drug-eluting implants that tend to migrate and cause side effects, or nasal sprays that offer short-term relief, SilexGel provides long-lasting effects with minimal side effects.